| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 21,2 k € | -83.5% | 128,2 k € | +20.9% | 106,0 k € | -16.0% | 126,3 k € | +13.9% | 110,8 k € | -2.6% | 113,8 k € | -0.6% | 114,5 k € | +9.4% | 104,6 k € | +15.5% | 90,5 k € | -29.1% | 127,6 k € | +5.0% | 121,6 k € | -18.5% | 149,1 k € | |
| EBITDA | -13,0 k € | -140.0% | 32,5 k € | +49.8% | 21,7 k € | -56.1% | 49,4 k € | +3.0% | 47,9 k € | -28.6% | 67,1 k € | +55.3% | 43,2 k € | +14.4% | 37,8 k € | +35.0% | 28,0 k € | -52.5% | 58,9 k € | -14.4% | 68,8 k € | -28.9% | 96,9 k € | |
| Operating profit | -24,3 k € | -204.4% | 23,3 k € | +1195.1% | -2,1 k € | -108.2% | 25,8 k € | +23.3% | 20,9 k € | -48.1% | 40,3 k € | +135.3% | 17,1 k € | +232.3% | -13,0 k € | +41.4% | -22,1 k € | -290.8% | 11,6 k € | -46.4% | 21,6 k € | -26.7% | 29,5 k € | |
| Profit/loss | -28,4 k € | -346.8% | 11,5 k € | +217.0% | -9,8 k € | -201.1% | 9,7 k € | +1.2% | 9,6 k € | -65.6% | 27,9 k € | +184.5% | 9,8 k € | +132.6% | -30,1 k € | +15.6% | -35,7 k € | -1475.8% | -2,3 k € | -145.3% | 5,0 k € | +210.3% | 1,6 k € | |
| Equity | 2,6 k € | -91.6% | 31,0 k € | +59.0% | 19,5 k € | -33.5% | 29,3 k € | +49.6% | 19,6 k € | +96.1% | 10,0 k € | +148.4% | -20,7 k € | +32.2% | -30,5 k € | -8582.8% | -351,0 € | -101.0% | 35,4 k € | -6.0% | 37,6 k € | +5.6% | 35,6 k € | |
| Total assets | 159,4 k € | -28.9% | 224,1 k € | -1.4% | 227,3 k € | -12.0% | 258,5 k € | -13.3% | 298,2 k € | -1.2% | 301,9 k € | -14.6% | 353,5 k € | +3.6% | 341,3 k € | -13.6% | 395,1 k € | -18.1% | 482,6 k € | -2.5% | 495,0 k € | -11.4% | 559,0 k € | |
| Cash | 22,3 k € | +278.3% | 5,9 k € | +12.4% | 5,3 k € | -2.8% | 5,4 k € | -35.0% | 8,3 k € | +44.1% | 5,8 k € | -67.9% | 18,0 k € | +74.4% | 10,3 k € | -61.6% | 26,9 k € | -57.0% | 62,4 k € | +126.0% | 27,6 k € | -56.1% | 62,9 k € | |
| Debts | 156,8 k € | -18.8% | 193,1 k € | -7.1% | 207,8 k € | -9.3% | 229,2 k € | -17.8% | 278,6 k € | -4.6% | 291,9 k € | -22.0% | 374,2 k € | +0.7% | 371,8 k € | -5.6% | 393,9 k € | -11.9% | 447,3 k € | -2.2% | 457,4 k € | -12.6% | 523,4 k € | |
| Staff | 0,8 | — | — | — | — | — | — | — | — | 1 | 1,1 | — | ||||||||||||
Private limited company · Seneffe · incorporated on 19/06/2012 · 0,8 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+278.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHAMALIMO is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 0,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette